BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao K, Zhao Y, Zhu JY, Dong H, Cong WM, Yu Y, Wang H, Zhu ZZ, Xu Q. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma. Curr Med Sci 2018;38:590-6. [PMID: 30128866 DOI: 10.1007/s11596-018-1918-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu ZZ, Bao LL, Zhao K, Xu Q, Zhu JY, Zhu KX, Wen BJ, Ye YQ, Wan XX, Wang LL, He SQ, Cong WM. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma. Curr Med Sci 2019;39:759-65. [PMID: 31612394 DOI: 10.1007/s11596-019-2103-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Wang B, Li H, Zhao X, Zhang W, Zhao G, Wu Z, Zhang R, Dong P, Watari H, Tigyi G, Li W, Yue J. A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways. J Cancer 2021;12:5654-63. [PMID: 34405025 DOI: 10.7150/jca.61066] [Reference Citation Analysis]
3 Peng G, Chai H, Ji W, Lu Y, Wu S, Zhao H, Li P, Hu Q. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma. BMC Med Genomics 2021;14:150. [PMID: 34103027 DOI: 10.1186/s12920-021-00998-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Litviakov NV, Ibragimova MK, Tsyganov MM, Doroshenko AV, Garbukov EY, Slonimskaya EM. Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with Metastasis. Curr Cancer Drug Targets 2020;20:681-8. [PMID: 31577208 DOI: 10.2174/1568009620666200506104523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Prince TL, Lang BJ, Guerrero-Gimenez ME, Fernandez-Muñoz JM, Ackerman A, Calderwood SK. HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity. Cells 2020;9:E1046. [PMID: 32331382 DOI: 10.3390/cells9041046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Rossi T, Palleschi M, Angeli D, Tebaldi M, Martinelli G, Vannini I, Puccetti M, Limarzi F, Maltoni R, Gallerani G, Fabbri F. Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient. Front Med (Lausanne) 2021;8:689895. [PMID: 34249978 DOI: 10.3389/fmed.2021.689895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wu F, Zhu Y, Zhou C, Gui W, Li H, Lin X. Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (PVT1) in human diseases. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.05.037] [Reference Citation Analysis]
8 Li D, Pan J, Zhang Y, Li Y, Jin S, Zhong C, Chen P, Ma J, Hu W, Fan X, Lin H. C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11. Cancers 2022;14:3410. [DOI: 10.3390/cancers14143410] [Reference Citation Analysis]